Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2018
Cash flows from operating activities:
Net income	$ 221,384	$ 132,465	$ 430,151
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	98,933	73,139	38,105
Amortization of intangibles	97,234	75,638	55,118
Amortization of debt issuance costs	10,743	6,189	1,570
Impairment charges	10,057	0	0
Foreign currency forward contract loss	0	70,777	0
Deferred income tax provision (benefit)	(11,212)	(9,059)	14,525
(Gain) loss on disposition of property, plant and equipment	3,990	739	(1,450)
Stock-based compensation expense	19,889	18,950	17,000
Changes in assets and liabilities:
Accounts receivable	(115,232)	136,145	(2,391)
Inventories	133,290	283,311	(77,421)
Prepaid income taxes, expenses and other	18,427	(13,114)	(14,197)
Accounts payable	60,469	(120,507)	(40,736)
Guarantee liabilities related to former EHG subsidiaries	0	(108,843)	0
Accrued liabilities and other	(14,059)	(46,612)	29,575
Long-term liabilities and other	7,028	8,801	16,659
Net cash provided by operating activities	540,941	508,019	466,508
Cash flows from investing activities:
Purchases of property, plant and equipment	(106,697)	(130,224)	(138,197)
Proceeds from dispositions of property, plant and equipment	27,677	2,732	3,835
Business acquisitions, net of cash acquired	0	(1,658,577)	0
Foreign currency forward contract payment related to business acquisition	0	(70,777)	0
Equity investment in joint venture	0	(6,500)	(50,402)
Other	(5,229)	(2,157)	1,271
Net cash used in investing activities	(84,249)	(1,865,503)	(183,493)
Cash flows from financing activities:
Borrowings on term-loan credit facilities	0	2,095,018	0
Borrowings on revolving asset-based credit facilities	379,222	100,000	0
Payments on term-loan credit facilities	(274,963)	(242,919)	0
Payments on revolving credit facilities	(379,986)	(100,000)	(145,000)
Payments on unsecured notes	0	(84,728)	0
Payments on other debt	(14,493)	(70,319)	0
Payments of debt issuance costs	0	(70,176)	0
Cash dividends paid	(88,318)	(84,139)	(77,989)
Payments on finance lease obligations	(442)	(405)	(378)
Payments related to vesting of stock-based awards	(3,763)	(4,418)	(7,657)
Other	(10,173)	1,159	0
Net cash provided by (used in) financing activities	(392,916)	1,539,073	(231,024)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	26,325	(5,576)	0
Net increase in cash and cash equivalents and restricted cash	90,101	176,013	51,991
Cash and cash equivalents and restricted cash, beginning of period	451,262	275,249	223,258
Cash and cash equivalents and restricted cash, end of period	541,363	451,262	275,249
Less: restricted cash	2,844	25,647	0
Cash and cash equivalents, end of period	538,519	425,615	275,249
Supplemental cash flow information:
Income taxes paid	56,803	87,813	218,841
Interest paid	101,784	57,189	3,901
Non-cash investing and financing transactions:
Capital expenditures in accounts payable	3,458	4,332	5,375
Common stock issued for business acquisition	$ 0	$ 144,168	$ 0